Mariprax

Pramipexole, the active ingredient in Mariprax, is a dopamine agonist presented as an oral tablet for oral use. It treats Parkinson's disease and restless legs syndrome in adults.

GNH USA supplies Mariprax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mariprax (pramipexole) is used in the management of dopaminergic disorders, primarily Parkinson's disease and related movement disorders.

- Parkinson's disease: improves motor symptoms and reduces off‑periods. - Restless legs syndrome: alleviates uncomfortable sensations and the urge to move. - Early Parkinsonian signs: helps delay the emergence of motor complications.

Pramipexole may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: sensation of light‑headedness, especially on standing. - Somnolence: increased sleepiness during the day. - Insomnia: difficulty initiating or maintaining sleep. - Constipation: reduced bowel movements. - Headache: mild to moderate cranial pain.

Serious or Rare Side Effects: - Hallucinations: visual or auditory disturbances. - Impulse control disorders: compulsive gambling, shopping, or eating. - Sudden onset of sleep: unexpected sleep episodes. - Orthostatic hypotension: marked blood pressure drop on standing. - Severe depression or suicidal thoughts. - Allergic reactions: rash, swelling, or anaphylaxis.

When prescribing pramipexole, clinicians should consider several safety measures.

- Dose titration: start low and increase gradually as directed by the prescriber. - Renal impairment: adjust dose based on renal function. - Elderly patients: monitor for excessive somnolence and falls. - Psychiatric history: watch for hallucinations, mood changes, or impulse control issues. - Pregnancy: safety not established; avoid unless benefit outweighs risk. - Store at room temperature: keep in the original container, protect from moisture and light.

Pramipexole can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - MAO‑B inhibitors: risk of hypertensive crisis. - Antipsychotics (e.g., haloperidol): antagonize pramipexole’s effect. - CYP2D6 inhibitors (e.g., fluoxetine): increase plasma concentrations.

Moderate Interactions (Monitor Closely): - Antihypertensives: may cause additive hypotension. - SSRIs: monitor for rare serotonin syndrome.